State Guidance for Implementation of Medicaid Drug Utilization Review (DUR) provisions included in Section 1004 of the SUPPORT Act
Guidance for : provisions included in Section 1004 of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (P.L. 115-271) This guidance provides information to the states concerning implementation of the new Medicaid Drug Utilization Review (DUR) provisions that were included in Section 1004 of the Substance Use- Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act, also referred to as the SUPPORT for Patients and Communities Act or the SUPPORT
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: August 05, 2019
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.